Torkhovskaya TI - Search Results

1

Lysophospholipid receptors in cell signaling.

Torkhovskaya TI, Ipatova OM, Zakharova TS, Kochetova MM, Khalilov EM. Torkhovskaya TI, et al. Biochemistry (Mosc). 2007 Feb;72(2):125-31. doi: 10.1134/s0006297907020010. Biochemistry (Mosc). 2007. PMID: 17367289 Review.

2

Sphingolipids and cell signaling: involvement in apoptosis and atherogenesis.

Ipatova OM, Torkhovskaya TI, Zakharova TS, Khalilov EM. Ipatova OM, et al. Among authors: torkhovskaya ti. Biochemistry (Mosc). 2006 Jul;71(7):713-22. doi: 10.1134/s0006297906070030. Biochemistry (Mosc). 2006. PMID: 16903825 Review.

3

Lipidomics: new approaches to the studies of cell signaling and prospects of use in medicine.

Torkhovskaya TI, Khalilov EM, Korotaeva AA. Torkhovskaya TI, et al. Bull Exp Biol Med. 2007 Sep;144(3):408-12. doi: 10.1007/s10517-007-0342-1. Bull Exp Biol Med. 2007. PMID: 18457046

4

Comparison of distribution characteristics of phosphatidylcholines and surfactant preparation.

Zakharova TS, Fortinskaya ES, Kochetova MM, Torkhovskaya TI, Khalilov EM. Zakharova TS, et al. Among authors: torkhovskaya ti. Bull Exp Biol Med. 2000 Apr;129(4):348-9. doi: 10.1007/BF02439265. Bull Exp Biol Med. 2000. PMID: 10977915

5

Influence of doxorubicin inclusion into phospholipid nanoformulation on its antitumor activity in mice: increased efficiency for resistant tumor model.

Zykova MG, Medvedeva NV, Torkhovskaya TI, Tikhonova EG, Prozorovskii VN, Zakharova TS, Ipatova OM. Zykova MG, et al. Among authors: torkhovskaya ti. Exp Oncol. 2012 Dec;34(4):323-6. Exp Oncol. 2012. PMID: 23302989

6

[The influence of doxorubicin incorporated in phospholipid drug delivery nanosystem on HEPG2 cells proteome].

Kuznetzova KG, Kazlas EV, Torkhovskaya TI, Karalkin PA, Vachrushev IV, Zakharova TS, Sanzhakov MA, Moshkovskiy SA, Ipatova OM. Kuznetzova KG, et al. Among authors: torkhovskaya ti. Biomed Khim. 2015 May-Jun;61(3):343-9. doi: 10.18097/PBMC20156103343. Biomed Khim. 2015. PMID: 26215411 Russian.

7

[Pharmacological targets for dislipidemies correction. Opportunities and prospects of therapeutic usage].

Kudinov VA, Zakharova TS, Torkhovskaya TI, Ipatova OM, Archakov AI. Kudinov VA, et al. Among authors: torkhovskaya ti. Biomed Khim. 2018 Jan;64(1):66-83. doi: 10.18097/PBMC20186401066. Biomed Khim. 2018. PMID: 29460837 Review. Russian.

8

[Improving of HDL capacity for macrophages cholesterol efflux after plasma incubation with phospholipid nanoparticles].

Kudinov VA, Zakharova TS, Torkhovskaya TI, Kashirtseva VA, Morosevich GE, Ipatova OM, Archakov AI. Kudinov VA, et al. Among authors: torkhovskaya ti. Biomed Khim. 2018 Jun;64(3):253-256. doi: 10.18097/PBMC20186403253. Biomed Khim. 2018. PMID: 29964261 Russian.

9

[Influence of doxorubicin inclusion into phospholipid nanoparticles on tumor accumulation and specific activity].

Medvedeva NV, Torkhovskaya TI, Kostryukova LV, Zakharova TS, Kudinov VA, Kasatkina EO, Prozorovskiy VN, Ipatova OM. Medvedeva NV, et al. Among authors: torkhovskaya ti. Biomed Khim. 2017 Jan;63(1):56-61. doi: 10.18097/PBMC2017630156. Biomed Khim. 2017. PMID: 28251952 Russian.

10

[Prednisolone in phospholipid nanoparticles: prolonged circulation and increased antiinflammatory effect].

Prozorovskii VN, Ipatova OM, Tikhonova EG, Zakharova TS, Druzhilovskaya OS, Korotkevich EI, Torkhovskaya TI. Prozorovskii VN, et al. Among authors: torkhovskaya ti. Biomed Khim. 2019 Apr;65(3):222-226. doi: 10.18097/PBMC20196503222. Biomed Khim. 2019. PMID: 31258145 Russian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters